Wells Fargo Maintains Overweight on Evolent Health, Lowers Price Target to $17

Wells Fargo analyst Jamie Stockton maintains Evolent Health (NYSE:EVH) with a Overweight and lowers the price target from $19 to $17.

Benzinga · 01/08/2020 15:51

Wells Fargo analyst Jamie Stockton maintains Evolent Health (NYSE:EVH) with a Overweight and lowers the price target from $19 to $17.